Comera Life Sciences Holdings Inc
OTC:CMRA

Watchlist Manager
Comera Life Sciences Holdings Inc Logo
Comera Life Sciences Holdings Inc
OTC:CMRA
Watchlist
Price: 0.0222 USD 0.45% Market Closed
Market Cap: 3.1k USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CMRA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CMRA Intrinsic Value
Not Available
Base Case Scenario
Compare CMRA to

Fundamental Analysis

Comera Life Sciences Holdings Inc
OTC:CMRA
US
Biotechnology
Market Cap
3.1k USD
IPO
Dec 15, 2020
US
Biotechnology
Market Cap
3.1k USD
IPO
Dec 15, 2020
Price
$
$
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CMRA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Comera Life Sciences Holdings Inc

Balance Sheet Decomposition
Comera Life Sciences Holdings Inc

Current Assets 2.6m
Cash & Short-Term Investments 1.8m
Receivables 100k
Other Current Assets 762.6k
Non-Current Assets 441.5k
PP&E 348.3k
Other Non-Current Assets 93.2k
Current Liabilities 2.9m
Accounts Payable 1.1m
Accrued Liabilities 1.2m
Other Current Liabilities 582.9k
Non-Current Liabilities 37.3k
Other Non-Current Liabilities 37.3k
Efficiency

Free Cash Flow Analysis
Comera Life Sciences Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Comera Life Sciences Holdings Inc

Revenue
1m USD
Cost of Revenue
-264.9k USD
Gross Profit
735.5k USD
Operating Expenses
-9.9m USD
Operating Income
-9.1m USD
Other Expenses
-206.5k USD
Net Income
-9.4m USD
Fundamental Scores

CMRA Profitability Score
Profitability Due Diligence

Comera Life Sciences Holdings Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Operating Margin is Increasing
Strong 3Y Average Gross Margin
Net Margin is Increasing
18/100
Profitability
Score

Comera Life Sciences Holdings Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

CMRA Solvency Score
Solvency Due Diligence

Comera Life Sciences Holdings Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
47/100
Solvency
Score

Comera Life Sciences Holdings Inc's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CMRA Price Targets Summary
Comera Life Sciences Holdings Inc

There are no price targets for CMRA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Comera Life Sciences Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CMRA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CMRA Insider Trading
Buy and sell transactions by insiders